| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | SERA Sera Prognostics, Inc. | Kearney Paul81 | Chief Data Officer | Sell | 1,396 | $2.04 | $2,847.84 | -0.8% | - | - | |
| Mar 11, 2026 | EW Edwards Lifesciences Corporation | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 13,000 | $84.92 | $1,103,895.79 | -13.0% | - | - | |
| Mar 11, 2026 | EW Edwards Lifesciences Corporation | Lippis Daniel J.62 | Cvp, Tavr | Sell | 1,019 | $85.38 | $87,004.46 | -2.9% | - | - | |
| Mar 11, 2026 | AVHHL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 1,800 | $4.78 | $8,604.00 | +1.3% | - | - | |
| Mar 11, 2026 | RPID Rapid Micro Biosystems, Inc. | Wilson John J. Addington | Chief Operating Officer | Sell | 9,603 | $4.32 | $41,466.71 | -2.9% | - | - | |
| Mar 11, 2026 | NMTC Neuroone Medical Technologies Corporation | Christianson Mark72 | Business Development Director | Sell | 13,720 | $0.80 | $10,976.00 | -3.1% | - | - | |
| Mar 11, 2026 | SERA Sera Prognostics, Inc. | Aerts Austin82 | Chief Financial Officer | Sell | 7,088 | $1.92 | $13,609.86 | -1.3% | - | - | |
| Mar 11, 2026 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya81 | Chief Executive Officer | Sell | 25,612 | $1.92 | $49,079.02 | -1.7% | - | - | |
| Mar 10, 2026 | MDLN Medline Inc. | Carlyle Group Inc.65 | 10% Owner | Sell | 26,105,840 | $41.00 | $1,070,339,440.00 | -17.0% | - | - | |
| Mar 10, 2026 | RPID Rapid Micro Biosystems, Inc. | Spignesi Robert G. Jr.53 | President And CEO | Sell | 17,922 | $4.11 | $73,686.30 | -1.5% | - | - | |
| Mar 10, 2026 | PRCT Procept Biorobotics Corporation | Nouri Alaleh51 | EVP, CLO, Corp. Sec. | Sell | 3,243 | $25.65 | $83,197.26 | -1.4% | - | - | |
| Mar 10, 2026 | ISRG Intuitive Surgical, Inc. | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 105 | $493.95 | $51,864.75 | -100% | - | - | |
| Mar 10, 2026 | MDLN Medline Inc. | Cp Circle Ml Holdco Gp, LLC | 10% Owner | Sell | 26,105,840 | $41.00 | $1,070,339,440.00 | -17.0% | - | - | |
| Mar 10, 2026 | MDLN Medline Inc. | Tc Group Cayman Investment Holdings, L.P.68 | 10% Owner | Sell | 26,105,840 | $41.00 | $1,070,339,440.00 | -17.0% | - | - | |
| Mar 10, 2026 | MDLN Medline Inc. | Hellman & Friedman Capital Partners X (parallel), L.P. | 10% Owner | Sell | 26,131,237 | $40.51 | $1,058,524,148.40 | -22.8% | - | - | |
| Mar 10, 2026 | MDLN Medline Inc. | Bx Mozart Ml-2 Holdco L.P. | 10% Owner | Sell | 27,852,986 | $40.51 | $1,128,268,756.89 | -18.6% | - | - | |
| Mar 10, 2026 | MDLN Medline Inc. | Carlyle Mozart Coinvestment Holdings, L.P. | 10% Owner | Sell | 26,105,840 | $41.00 | $1,070,339,440.00 | -17.0% | - | - | |
| Mar 10, 2026 | ENOV Enovis Corporation | Engert Oliver | Chief Administrative Officer | Buy | 1,000 | $23.93 | $23,930.00 | +2.1% | - | - | |
| Mar 10, 2026 | AVTR Avantor, Inc. | Mehra Sanjeev K | Director | Buy | 125,000 | $8.01 | $1,001,250.00 | +35.7% | - | - | |
| Mar 10, 2026 | MDLN Medline Inc. | Bcp 8 Holdings Mozart Manager L.l.c. | 10% Owner | Sell | 27,852,986 | $40.51 | $1,128,268,756.89 | -18.6% | - | - | |
| Mar 9, 2026 | RSMDF Resmed Inc. | Farrell Michael J.62 | Chairman And CEO | Sell | 4,991 | $251.03 | $1,252,901.71 | -1.1% | - | - | |
| Mar 9, 2026 | ISRG Intuitive Surgical, Inc. | Brosius Mark52 | SVP &Chief Mfg And Supply Cha | Sell | 1,293 | $487.61 | $630,474.57 | -25.0% | - | - | |
| Mar 9, 2026 | CERS Cerus Corporation | Benjamin Richard J74 | Chief Medical Officer | Sell | 125,894 | $1.99 | $250,937.78 | -4.4% | - | - | |
| Mar 9, 2026 | PRCT Procept Biorobotics Corporation | Desai Antal Rohit81 | Director | Buy | 426,262 | $24.59 | $10,482,942.96 | +25.0% | - | - | |
| Mar 9, 2026 | CERS Cerus Corporation | Benjamin Richard J74 | Chief Medical Officer | Sell | 125,894 | $1.99 | $250,931.66 | -4.4% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.